Robert Matthew Lutz - 29 Aug 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role: Chief Financial & Business Officer and Principal Accounting Officer
Signature: /s/Robert Matthew Lutz
Issuer symbol: IBIO
Transactions as of: 29 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 31 Aug 2022, 16:01:06 UTC
Previous filing: 14 Mar 2022
Next filing: 15 Nov 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IBIO	Stock Option (right to buy)	Award	$0	+400,000		$0.000000	400,000	29 Aug 2022	Common Stock	400,000	$0.2800	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

Remarks:

Chief Financial & Business Officer and Principal Accounting Officer